Handelsavisen
prelaunch
Companies Healthcare 9527.SE
95
9527.SE Tadawul Medical Equipment, Supplies & Distribution

Alf Meem Yaa for Medical Supplies and Equipment Company SJSC

$75,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
2,49 %
Op margin
14,1 %
ROE
19,5 %
Net margin
11,5 %
Debt / equity
0,16
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Alf Meem Yaa for Medical Supplies and Equipment Company SJSC provides medical equipment and supplies, primarily generating revenue through the distribution and sale of healthcare products.

Business. Alf Meem Yaa for Medical Supplies and Equipment Company SJSC operates in the medical equipment, supplies, and distribution industry within the healthcare sector. The company is headquartered in Saudi Arabia and is listed on the Tadawul stock exchange under the ticker symbol 9527.SE. Specific details regarding its operating segments and geographic revenue mix are not disclosed.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
BUY1 analysts
1 buy0 hold0 sell
Avg 12m price target184,00

Analyst recommendations

1 analysts · consensus Buy
Buy1
Hold0
Sell0
12-month price target
184,00
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
1 analysts · indicative
Ownership
not yet wired
Profitability
19,5 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 9527.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 9527.SE. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Alf Meem Yaa for Medical Supplies and Equipment Company SJSC operates in the medical equipment, supplies, and distribution industry within the healthcare sector. The company is headquartered in Saudi Arabia and is listed on the Tadawul stock exchange under the ticker symbol 9527.SE. Specific details regarding its operating segments and geographic revenue mix are not disclosed.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    The company maintains a strong liquidity position with a current ratio of 3.28, indicating that it has more than three times the current assets to cover its current liabilities. However, its operating cash flow is negative at -26,025,970 SAR, which may signal short-term cash flow challenges despite the high current ratio. The debt-to-equity ratio is 0.16, suggesting a conservative capital structure with limited leverage.

    Profitability metrics show a return on equity (ROE) of 19.54% and a return on assets (ROA) of 12.75%, both of which are strong and indicate efficient use of equity and assets to generate profit. The gross profit margin is 42.14% (128,487,180 SAR / 304,963,330 SAR), and the operating margin is 14.07% (42,902,190 SAR / 304,963,330 SAR), both of which are solid and suggest effective cost control and pricing power.

    The company operates in a single business segment, with no disclosed geographic diversification. All revenue is attributed to one segment, indicating a lack of diversification risk but also a concentration risk if demand in this segment declines.

    Looking ahead, the company is expected to maintain its revenue trajectory, with no specific growth or decline percentages provided in the outlook. However, the negative operating cash flow and the presence of long-term debt (27,773,840 SAR) may pose challenges to sustaining growth without additional financing.

    The risk assessment highlights a medium liquidity risk due to the negative net cash position after subtracting total debt. The dilution risk is low, with no near-term pressure expected, and no recent dilutive events reported. Analysts have provided a mean recommendation of 2.00, indicating a "Buy" rating, with one analyst recommending a buy and none recommending a strong buy or hold.

    Recent events include the latest financial filing, which shows a net income of 35,008,810 SAR and a free cash flow of 21,438,800 SAR. No recent earnings call transcripts or major corporate events were disclosed in the available data.

    Key takeaways
    • The company has a strong ROE of 19.54% and ROA of 12.75%, indicating efficient use of equity and assets.
    • A current ratio of 3.28 suggests a strong liquidity position, but the negative operating cash flow may signal short-term cash flow challenges.
    • The company operates in a single business segment with no geographic diversification, indicating a concentration risk.
    • Analysts have provided a "Buy" rating, with a mean recommendation of 2.00 and one analyst recommending a buy.
    • The debt-to-equity ratio is 0.16, indicating a conservative capital structure with limited leverage.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $75,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $179.2M
    Net cash
    -$27.8M
    Current ratio
    3.3
    Debt / equity
    0.2
    ROA
    12.8%
    ROE
    19.5%
    Cash conversion
    -74.0%
    CapEx / revenue
    -0.4%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    8,40
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    1
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-14 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate8,40
    Revenueno estimateno estimate343,0M SAR
    Operating incomeno estimateno estimate60,1M SAR
    Full-year consensus mean (period as reported by source) · consensus in SAR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution1 analysts
    Strong buy0
    Buy1
    Hold0
    Sell0
    Strong sell0
    12-month price target$184,00 · Median $184,00
    Low $184,00High $184,00
    Operating income · consensus60,1M SAR
    EPS surprise
    −40,5 %
    reported vs consensus · miss
    Revenue surprise
    −11,1 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$184,00
    Mean$184,00
    Median$184,00
    High$184,00
    Spot$75,00
    +145.3 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin14,1 %Above median
    Net Margin11,5 %Above P75
    ROE19,5 %Best in class
    Capex / Rev-0,4 %Above P75
    D/E0,16Above median
    Cash Conv-0,74Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Alf Meem Yaa for Medical Supplies and Equipment Company SJSC Market data — financials · 2026-05-27
    • Alf Meem Yaa for Medical Supplies and Equipment Company SJSC Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    9527.SECanonical
    Tadawul · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage